Fresenius Kabi Final Site and Operational Plans

    Fresenius Kabi Final Site and Operational Plans
    Posted on 08/12/2019
    On Monday, August 12, the Pleasant Prairie Plan Commission considered and approved final site and operational plans for Fresenius Kabi. The request was made by Steve Miller with Clayco, on behalf of the property owners Bluepoint 94 LLC, for the construction of a 590,525 square foot regional office and pharmaceutical storage and processing facility to be located at 11900 122nd Street in Stateline 94 Corporate Park.

    Fresenius Kabi is a global healthcare company specializing in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition applications. Their products and services are used to help care for critically and chronically ill patients and the company is committed to putting essential medicines and technologies into the hands of the people who help patients find the best answers to the healthcare challenges the face. Fresenius Kabi provides high-quality products with one of the most comprehensive product portfolios for core therapeutic areas.

    The hours of operation will be 4:00 a.m. to 11:00 p.m. with two shifts. It is estimated to have 95 employees within the first three years and it is anticipated that the number of employees could reach up to 164 employees by 2028. These workers will be skilled in operating equipment as well as all regulations related to cGMP, Drug Supply Chain Security, and DEA requirements. They have a full electronic training system that ensures employees are trained on appropriate policies and procedures for their particular job function.

    Fresenius Kabi is plans to take occupy of the building in spring of 2020.
    Village of Pleasant Prairie | All Rights Reserved | Powered by CivicLive | © 2019 Intrado Corporation.